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Toxin–antitoxin (TA) systems, which consist of an intracellular toxin and its antidote
(antitoxin), are encoded by ubiquitous genetic modules in prokaryotes. Commonly,
the activity of a toxin is inhibited by its antitoxin under normal growth conditions.
However, antitoxins are degraded in response to environmental stress, and toxins
liberated from antitoxins consequently induce cell death or growth arrest. In free-living
prokaryotes, TA systems are often present in large numbers and are considered to
be associated with the adaptation of pathogenic bacteria or extremophiles to various
unfavorable environments by shifting cells to a slow growth rate. Genomic analysis of
the human pathogen Mycobacterium tuberculosis H37Rv (Mtb) revealed the presence
of a large number of TA systems. Accordingly, we investigated five uncharacterized TA
systems (Rv2019-Rv2018, Rv3697c-Rv3697A, Rv3180c-Rv3181c, Rv0299-Rv0298,
and Rv3749c-Rv3750c) of Mtb. Among these, the expression of the Rv2019 toxin
inhibited the growth of Escherichia coli, and M. smegmatis and this growth defect was
recovered by the expression of the Rv2018 antitoxin. Interestingly, Rv3180c was toxic
only in M. smegmatis, whose toxicity was neutralized by Rv3181c antitoxin. In vivo and
in vitro assays revealed the ribosomal RNA (rRNA) cleavage activity of the Rv2019 toxin.
Moreover, mRNAs appeared to be substrates of Rv2019. Therefore, we concluded that
the ribonuclease activity of the Rv2019 toxin triggers the growth defect in E. coli and
that the Rv2018 antitoxin inhibits the ribonuclease activity of the Rv2019 toxin.
Keywords: toxin, antitoxin, VapBC, MazEF, Mycobacterium tuberculosis
INTRODUCTION
Toxin–antitoxin (TA) systems are encoded by ubiquitous genetic modules as an operon in
prokaryotes and consist of an intracellular toxin and its antidote (antitoxin) (Ramage et al., 2009).
Previously, these systems were known as plasmid addiction modules of large plasmids with low
copy numbers (Van Melderen et al., 1994). The control of cell death (ccd) system was first identified
as a TA system in the Escherichia coli F plasmid (Jaffe et al., 1985); it is organized as an operon
that contains two genes encoding a toxic protein (CcdB toxin) and an antidote protein (CcdA
antitoxin). When cells are carrying the F plasmid after division, the ccdB toxin and ccdA antitoxin
are simultaneously expressed and form a stable TA (CcdB–CcdA) complex that neutralizes toxin
activity. However, when the F plasmid is lost by chance during cell division, the CcdA antitoxins
remaining in plasmid-free daughter cells are rapidly degraded by the Lon protease. Consequently,
CcdB toxins released from the CcdB–CcdA complex interact with their target, DNA gyrase,
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leading to double-strand DNA breaks and ultimately to cell death.
Similarly, other plasmid-borne TA systems have been identified
as post-segregational killing systems (Gerdes et al., 1990; Jiang
et al., 2002) that play a particularly important role in the
maintenance of virulence plasmids in pathogenic bacteria (Hayes,
2003; De la Cruz et al., 2013). However, numerous TA systems
have recently been discovered; these are encoded by prokaryotic
genomes and are commonly considered stress-responsive genetic
modules (Sevin and Barloy-Hubler, 2007; Shao et al., 2011).
At present, TA systems are classified into five types according
to the nature and mode of action of the antitoxin that counteracts
the activity of the toxin (Unterholzner et al., 2013). Toxins are
proteins, and antitoxins are either proteins (Types II, IV, and V)
or small RNAs (Types I and III) (Schuster and Bertram, 2013).
In the Type I system, RNA antitoxins that are complementary to
toxin transcripts bind to toxin mRNAs and arrest the translation
of toxin mRNAs (Gerdes et al., 1990; Vogel et al., 2004; Weaver
et al., 2004; Kawano et al., 2007; Fozo et al., 2008). The toxins
and antitoxins of Type II systems are proteins, and most toxins
function as endoribonucleases that target rRNA, mRNA, or
tRNA. The antitoxin directly associates with its cognate toxin to
antagonize the activity of the latter (Jiang et al., 2002; Zhang Y.
et al., 2003; Munoz-Gomez et al., 2005; Liu et al., 2008; Jorgensen
et al., 2009; Schumacher et al., 2009; Hallez et al., 2010; Winther
and Gerdes, 2011; Zhang and Inouye, 2011; Brzozowska and
Zielenkiewicz, 2013). In the Type III system, the toxin protein
is inactivated by binding to RNA antitoxin fragments cleaved
by the ribonuclease of the toxin (Fineran et al., 2009; Blower
et al., 2012). Unlike the Type II system, toxins and antitoxins
of the Type IV system do not interact directly, and antitoxins
protect the target of the toxin, reversing the effect of the toxin
(Masuda et al., 2012a,b). In the Type V system, the ribonuclease
activity of the antitoxin can degrade the toxin mRNA (Wang
et al., 2012).
Surprisingly, a relatively enormous number (79) of TA systems
have been identified in the human pathogen Mycobacterium
tuberculosis H37Rv (Mtb), and notably, unlike the related non-
pathogenic mycobacterial species, members of the M. tuberculosis
complex, M. microti, M. bovis, M. africanum, and M. canetti,
encode an equally large number of TA systems (66, 65, 65,
and 60, respectively) (Ramage et al., 2009). Considering this
conservation, the TA systems of pathogenic Mycobacteria may
be related to their pathogenesis, persistence, virulence, and
biofilm formation. Therefore, to investigate the important role
of the TA system of Mtb, we selected 4 uncharacterized TA
systems of the VapBC TA family (Rv2019-Rv2018, Rv3697c-
Rv3697A, Rv3180c-Rv3181c, and Rv3749c-Rv3750c) as well as
1 TA system homologous to the MazEF TA family (Rv0299-
Rv0298). Among these, we showed that expression of the Rv2019
toxin inhibited the growth of E. coli and that this growth
defect was recovered by expression of the Rv2018 antitoxin. In
vitro studies showed that the ribosomal RNA (rRNA) cleavage
activity of the Rv2019 toxin requires a divalent metal ion.
Therefore, we concluded that the ribonuclease activity of the
Rv2019 toxin triggers a growth defect in E. coli and that the
Rv2018 antitoxin inhibits the ribonuclease activity of the Rv2019
toxin.
MATERIALS AND METHODS
Bacterial Strains and Growth Conditions
The bacterial strains used in this study are listed in Table 1.
For all studies, bacterial strains were grown with aeration at
37◦C. E. coli BL21(DE3) was grown in LB or M9 minimal media
supplemented with casamino acids and 0.2% glucose or 0.2%
glycerol. M. smegmatis mc2 155 was grown in Middlebrook 7H9
(a liquid medium, Difco) containing 0.2% glycerol and 0.02%
Tween 80 or Middlebrook 7H10 (a solid agar medium, Difco)
containing 0.2% glycerol. Chloramphenicol (Cm) or ampicillin
(Amp) was added to a concentration of 50 µg/ml to cultures of
E. coli, and kanamycin was added to a concentration of 50 µg/ml
to cultures of E. coli and 25 µg/ml to cultures of M. smegmatis.
Plasmid Construction
To construct plasmids, toxin and antitoxin genes were amplified
from Mtb genomic DNA by polymerase chain reaction (PCR).
The amplified PCR fragments were subcloned into the SmaI
site of pUC19, and the sequences of the amplicons were
verified using DNA sequencing. Using DNAs digested by the
appropriate restriction enzymes, toxin genes were subsequently
cloned into the NdeI-HindIII sites (for Rv2019, Rv3180c,
Rv3697c, or Rv0299) or NdeI-XbaI sites (for Rv3749c) of the
pBAD33 vector containing pA15 origin of replication (∼20
copies per cell) the arabinose-inducible (araBAD) promoter
(Guzman et al., 1995) to generate pBAD33-Rv2019, pBAD33-
Rv3180c, pBAD33-Rv3697c, pBAD33-Rv0299, and pBAD33-
Rv3749c. Antitoxin genes were cloned into the NdeI-EcoRI
sites of the pET21c vector containing an isopropyl β-D-1-
thiogalactopyranoside (IPTG)-inducible T7 promoter to generate
pET21c-Rv2018, pET21c-Rv3181c, pET21c-Rv3697A, pET21c-
Rv0298, and pET21c-Rv3750c.
To construct a plasmid expressing a chimeric glutathione
S-transferase (GST) Rv2019 protein (pGST-Rv2019), pET21c-
Rv2019 was digested with NdeI and XhoI, and the Rv2019
fragment was ligated into the NdeI-XhoI sites of the pGST
vector containing an IPTG-inducible T7-lac promoter. To
express the toxins in M. smegmatis, pUC19-toxin subclones
were digested with NdeI and XbaI, and the resulting fragment
was ligated into the NdeI-XbaI sites of the pMV306AC vector
containing an acetamide-inducible promoter (Stover et al., 1991).
To construct Rv2019 mutant clones, the primers listed in
Supplementary Table S1 were used to amplify gene fragments,
and the resulting DNA fragments harboring mutation were
inserted into pBAD33, yielding pBAD33-Rv2019D4K , pBAD33-
Rv2019E41K , and pBAD33-Rv2019D98K . All plasmids used in this
study are listed in Table 1.
Rv2019-Rv2018 Neutralization Assay
Overnight cultures of BL21(DE3) harboring compatible plasmid
pairs (pBAD33 and pET21c, pBAD33-Rv2019 and pET21c,
pBAD33 and pET21c-Rv2018, or pBAD33-Rv2019 and pET21c-
Rv2018) were diluted 102-fold in fresh M9 minimal media
containing Cm and Amp, and the diluted cultures were grown
to the exponential phase at 37◦C. The cells were harvested by
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TABLE 1 | Bacterial strains and plasmids used in this study.
Strains/Plasmids Genotypes Reference
BW25113 E. coli, F−,1(araD-araB)567,1lacZ4787(::rrnB-3), λ−, rph-1,1(rhaD-rhaB)568, hsdR514 E. coli Genetic Resources at Yale CGSC
BL21(DE3) E. coli, F−, lon-11,1(ompT-nfrA)885,1(galM-ybhJ)884,λDE3 [lacI, lacUV5-T7 gene 1, ind1,
sam7, nin5], 146, [mal+]K−12(λS), hsdS10
E. coli Genetic Resources at Yale CGSC
M. smegmatis mc2155 M. smegmatis, ept-1 Snapper et al., 1988
pBAD33 araBAD promoter, pACYC184 ori, CmR Guzman et al., 1995
pET21c T7 promoter, pBR322 ori, AmpR Novagen
pGST T7-lac promoter, pBR322 ori, KanR Ogawa et al., 1996
pMV306AC Acetamide promoter, oriE, KanR, E. coli-Mycobacterium shuttle vector Stover et al., 1991
pBAD33-Rv2019 Rv2019+ (toxin), pBAD33 This study
pBAD33-Rv2019D4K Rv2019D4K (toxin), pBAD33 This study
pBAD33-Rv2019E41K Rv2019E41K (toxin), pBAD33 This study
pBAD33-Rv2019D98K Rv2019D98K (toxin), pBAD33 This study
pBAD33-Rv3697c Rv3697c+ (toxin), pBAD33 This study
pBAD33-Rv3180c Rv3180c+ (toxin), pBAD33 This study
pBAD33-Rv0299 Rv0299+ (toxin), pBAD33 This study
pBAD33-Rv3749c Rv3749c+ (toxin), pBAD33 This study
pBAD33-Rv2018 Rv2018+ (antitoxin), pBAD33 This study
pET21c-Rv2019 Rv2019+ (toxin), pET21c This study
pET21c-Rv2019His Rv2019+ (toxin), pET21c, C-terminal His-tag This study
pET21c-Rv2018 Rv2018+ (antitoxin), pET21c This study
pET21c-Rv3697A Rv3697A+ (antitoxin), pET21c This study
pET21c-Rv3181c Rv3181c+ (antitoxin), pET21c This study
pET21c-Rv0298 Rv0298+ (antitoxin), pET21c This study
pET21c-Rv3750c Rv3750c+ (antitoxin), pET21c This study
pGST-Rv2019 Rv2019+ (toxin), pGST This study
pGST-Rv3697c Rv3697c+ (toxin), pGST This study
pGST-Rv3180c Rv3180c+ (toxin), pGST This study
pGST-Rv0299 Rv0299+ (toxin), pGST This study
pGST-Rv3749c Rv3749c+ (toxin), pGST This study
pMV306AC-Rv2019 Rv2019+ (toxin), pMV306AC This study
pMV306AC-Rv2018-2019 Rv2018+ (antitoxin), Rv2019+ (toxin), pMV306AC This study
pMV306AC-Rv3697c Rv3697c+ (toxin), pMV306AC This study
pMV306AC-Rv3180c Rv3180c+ (toxin), pMV306AC This study
pMV306AC-Rv3180c-3181c Rv3180c+ (toxin), Rv3181c+ (antitoxin), pMV306AC This study
pMV306AC-Rv0299 Rv0299+ (toxin), pMV306AC This study
pMV306AC-Rv3749c Rv3749c+ (toxin), pMV306AC This study
AmpR, ampicillin resistance; KanR, Kanamycin resistance; CmR, Chloramphenicol resistance.
centrifugation and resuspended in M9 minimal media to an
optical density at 600 nm (OD600) = 0.2. The resuspension
was diluted 10−1, 10−2, 10−3, and 10−4-folds, and each diluted
sample was spotted onto M9 agar plates containing Cm and
Amp with 0.2% L-arabinose, 0.05 mM IPTG, or both or without
inducers. The plates were incubated overnight at 37◦C. For
a neutralization assay in liquid culture, BL21(DE3) harboring
pBAD33-Rv2019 and pET21c-Rv2018 were grown at 37◦C to the
exponential phase in M9 minimal media containing Cm and
Amp. The cultures were diluted fivefold in the same minimal
media, and inducers were added as follows: 0.2% L-arabinose,
0.05 mM IPTG, or both. The diluted cultures were incubated
at 37◦C for 2 h and continuously diluted fivefold in fresh M9
minimal media containing inducers every 2 h, and OD600 was
measured.
Purification of GST and GST-Rv2019
Overnight cultures of BL21(DE3) transformed with pGST or
pGST-Rv2019 were diluted 50-fold in 1 L of fresh LB media
containing kanamycin and incubated at 37◦C until OD600
reached 0.5–0.6. IPTG was added to 0.5 mM, and the cultures
were further incubated with shaking (200 rpm) at 37◦C for 2 h.
The cells were centrifuged for 20 min at 4,000 × g, and the cell
pellet was washed in 30 ml of 20 mM Tris–HCl (pH 6.8). The
washed cells were centrifuged again and resuspended in 20 ml
(for GST) or 66 ml (for GST-Rv2019) of lysis buffer [50 mM
Tris–HCl (pH 8.0), 100 mM NaCl, 5 mM β-mercaptoethanol]
with (for GST-Rv2019) or without (for GST) sarkosyl
(N-lauroylsarcosine). The resuspended cells were lysed using a
sonicator. Lysates were centrifuged for 25 min at 10,000 × g,
and the supernatant was centrifuged for 1 h at 180,000 × g in
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a Beckman 70Ti rotor. The final supernatant was loaded onto
a glutathione agarose column that was equilibrated with 10
column volumes of lysis buffer. The column was washed with
30 column volumes of lysis buffer, and bound proteins were
eluted with 10 1-ml aliquots of elution buffer containing 10 mM
reduced glutathione. The eluted proteins were dialyzed twice
overnight against 2 L of storage buffer [50 mM Tris–HCl (pH
8.0), 100 mM NaCl].
Extraction of Total RNA
The hot phenol method was used to extract total cellular RNA
(Sarmientos et al., 1983). BL21(DE3) was grown to OD600 = 1.0,
and 1.5 ml of the culture was centrifuged for 2 min at 17,000× g.
Pelleted cells were resuspended in 500 µl of solution A (20 mM
sodium acetate, 10 mM EDTA, 0.5% SDS), and an equal volume
of hot phenol was added, followed by incubation for 10 min
at 60◦C. After centrifugation for 10 min at 17,000 × g, 400 µl
of the aqueous phase was mixed with 40 µl of 3 M sodium
acetate (pH 4.3). In total, 1 ml of ice-cold ethanol was added to
the mixture, which was incubated for 30 min at −20◦C. RNA
was collected by centrifugation for 10 min at 17,000 × g. The
pellet was resuspended in 200 µl of solution B (20 mM sodium
acetate, 10 mM EDTA) and mixed with 20 µl of 3 M sodium
acetate (pH 4.3). Next, 1 ml of ice-cold ethanol was added,
and the sample was incubated for 30 min at −20◦C. RNA was
collected by centrifugation for 10 min at 17,000 × g. The pellet
was washed with 200 µl of 75% ethanol and dissolved in 50 µl
of distilled water. The quality of RNA was assessed using agarose
gel electrophoresis, and the RNA concentration was determined
using Thermo Scientific NanoDrop 2000.
rRNA Cleavage Assay
For the in vivo assay, BL21(DE3) harboring pBAD33 or pBAD33-
Rv2019 was grown to OD600 = 0.6–0.7 in M9 minimal
media containing Cm. The cultures were diluted fivefold in
fresh M9 media supplemented with 0.2% L-arabinose, and the
diluted cultures were incubated at 37◦C for 2 h. Cultures
were continuously diluted fivefold in fresh M9 minimal media
containing inducer every 2 h. After induction for 0, 2, 4,
or 6 h, equal numbers of cells were harvested according to
OD600, and the pellets were resuspended in 100 µl of 20 mM
Tris–HCl (pH 6.8). An equal volume of phenol (pH 8.0) was
added, which was vortexed to lyse the cells, and the aqueous phase
was electrophoresed through 1.2% agarose gel. For the in vitro
assay, total RNAs were extracted from BL21(DE3), as described
earlier. The reaction buffer containing 50 mM Tris–HCl (pH 8.0)
and the purified protein (15 pmole of GST or GST-Rv2019) was
incubated with 2 µg of RNA at 37◦C. At the indicated times,
reactions were stopped by adding 3 µl of 6x RNA loading buffer
[10 mM Tris–HCl (pH 7.5), 0.03% bromophenol blue, 0.03%
xylene cyanol FF, 60% glycerol, and 60 mM EDTA]. The samples
were electrophoresed through 1.2% agarose gel, and RNAs were
visualized using ethidium bromide.
Quantitative Real-Time PCR (qRT-PCR)
BL21(DE3) harboring pBAD33 or pBAD33-Rv2019 was grown
to the exponential phase, and the culture was diluted 10-fold
in fresh M9 minimal medium containing Cm. L-arabinose was
added to the diluted culture to a final concentration of 0.2%.
Next, the cultures were incubated with shaking (200 rpm) at
37◦C for 4 h; the cultures were then diluted 10-fold in fresh
M9 minimal media containing Cm and 0.2% L-arabinose and
incubated at 37◦C. After 8 h, the same amounts of cells were
harvested, and total RNAs were extracted using the hot phenol
method, as described above. RNase-free DNase (Qiagen) was
treated to remove contaminating genomic DNA, according to the
manufacturer’s instructions. After DNase treatment, the quality
of total RNA was assessed using agarose gel electrophoresis, and
the RNA concentration was determined using Thermo Scientific
NanoDrop 2000. Complementary DNA (cDNA) was synthesized
using the Superscript III First Strand Synthesis for RT-PCR Kit
(Invitrogen) with 1 µg of total RNA. The StepOne Plus Real-
time PCR System (Applied Biosystems) was used to amplify 1 µl
of cDNA added to SYBR Green master mix (Qiagen). The eight
pairs of primers used for qRT-PCR are listed in Supplementary
Table S1. Thermocycling conditions were as follows: initial
denaturation for 15 min at 95◦C, followed by 40 cycles at 95◦C
for 5 s, 55◦C or 59◦C (only for reaction using the glyS2 primers)
for 30 s, and 72◦C for 50 s.
Construction of M. smegmatis Strains
Carrying Genomic Expression Cassettes
Encoding Toxins
The shuttle vector pMV306AC lacking a mycobacterial origin
of replication was used for integration, which occurs between
the attP site of the vector and the attB site of M. smegmatis
genomic DNA (Stover et al., 1991). Rv2019, Rv2018-2019,
Rv3180c, Rv3180c-3181c, Rv3697c, Rv3749c, or Rv0299 was
each cloned into the NdeI-XbaI sites of the acetamide-
inducible pMV306AC vector to generate pMV306AC-Rv2019,
pMV306AC-Rv2018-2019, pMV306AC-Rv3180c, pMV306AC-
Rv3180c-3181c, pMV306AC-Rv3697c, pMV306AC-Rv3749c, or
pMV306AC-Rv0299, respectively. Electroporation was used to
introduce the plasmids into M. smegmatis mc2 155 (Snapper
et al., 1990). Single colonies of transformed cells were selected
by plating the cultures onto agar plates containing kanamycin.
Colony PCR was performed to confirm the integration of the
plasmid into the bacterial genome (data not shown).
RESULTS
Assessment of the Toxic Effects of 5 Mtb
TA Systems on the Growth of E. coli
The Mtb genome encodes 79 TA systems as follows: 10 MazF
homologs, 50 VapC homologs, 2 RelE homologs, 3 HigB
homologs, 2 ParE homologs, 1 YoeB homolog, and 11 putative
TA systems (Sala et al., 2014). Notably, because of the numerous
TA systems in Mtb, some TA modules were characterized to
identify their TA functions; however, the functional mechanisms
of most Mtb TA systems are unknown. Therefore, in the
present study, in order to elucidate functions of those TA
systems, we selected 4 VapBC TA systems (Rv2019-Rv2018,
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FIGURE 1 | Amino acid sequence alignments of VapC or MazF homologs. (A) Sequence alignments of Rv2019 with VapC homologs VapC30, Mtb VapC30
(GenBank accession number NP_215138.1); VapC1, Mtb VapC1 (CCP42788.1); and Rv2019, Mtb Rv2019 (NP_216535.1). The numbers correspond to amino acid
residue numbers and asterisks indicate four highly conserved acidic residues in VapC30. (B) Sequence alignments of Rv0299 with MazF homologs. Eco, Escherichia
coli MazF (GenBank accession number CDZ21577.1); Bsu, Bacillus subtilis MazF (P96622.1); Sau, Staphylococcus aureus MazF (AKB00150.1); and Rv0299, Mtb
Rv0299 MazF (CCP43029.1). Asterisks indicate seven amino acids residues in E. coli MazF that bind substrate. Identical and similar residues are enclosed in black
and white boxes, respectively.
Rv3697c-Rv3697A, Rv3180c-Rv3181c, and Rv3749c-Rv3750c)
and 1 MazEF TA system (Rv0299-Rv0298) of Mtb whose toxicities
are still unknown in Mtb as well as in E. coli.
VapC toxin homologs share sequence similarities with the PIN
domain, which is a PilT N-terminal domain (Arcus et al., 2011).
The three-dimensional structure of the active site of PIN domain
includes four highly conserved acidic residues that coordinate
the divalent metal ion. Notably, a cluster of metal ion-associated
acidic residues forms a cavity and plays an important role in
ribonuclease activity (Das et al., 2014). First, we compared the
amino acids sequences of four VapC homologs with those of
Mtb VapC1 and VapC30, each of which contains well-conserved
acidic residues. As shown in Figure 1A, the alignment of the
amino acids sequence of the Rv2019 toxin with those of the
Mtb VapC homologs (VapC1 and VapC30) showed relatively
low identities (6.87–10.52%) and similarities (10.68–20.61%).
Although the overall sequence conservation was poor, the three
acidic residues Asp4, Glu41, and Asp98 in Rv2019 were well
conserved. However, the fourth acidic residue was not conserved.
When the other three VapC homologs (Rv3180c, Rv3697c, and
Rv3749c) were aligned with Mtb VapC1 and VapC30, three acidic
residues were less well conserved (Supplementary Figure S1).
All Mtb MazF toxins appeared distantly related to known MazF
proteins of other bacteria (Ramage et al., 2009), and in the
case of Rv0299 toxin as a MazF homolog, the similarity and
identity scores of Rv0299 and MazF homologs in E. coli, Bacillus
subtilis, and Staphylococcus aureus were 9.9–12.61% and 5–8%,
respectively (Figure 1B).
To assess the toxic effects of five putative Mtb TA systems
on E. coli, we transformed BL21(DE3) with the pBAD33-toxin
plasmid and induced the expression of toxin genes using 0.2% L-
arabinose. The expression of the five mycobacterial TA systems in
cells grown on solid M9 media showed only that the expression
of Rv2019 inhibited colony formation of BL21(DE3) (Figure 2A).
Further, the expression of Rv3180c, Rv3697c, Rv3749c, and
Rv0299 did not influence colony formation of BL21(DE3). The
open reading frames of Rv2018, Rv3181c, Rv3697A, Rv3750c, and
Rv0298 were ligated to the pET21c vector containing an IPTG-
inducible (T7) promoter. In the presence of 0.05 mM IPTG, the
expression of the antitoxins did not affect cell growth, suggesting
that the antitoxin proteins were not toxic. Further, only the
Rv2019 toxin severely inhibited the growth of E. coli when each of
the five toxins was expressed in cells cultured in liquid M9 media
(Figure 2B). These results suggest that Mtb Rv2019 functions as
a toxin, at least in E. coli.
Next, to investigate whether the three acidic residues are
indispensable for the toxicity of the Rv2019 toxin, the mutations
D4K, E41K, and D98K were individually introduced into the
primary sequence of the Rv2019 toxin. In Figure 2C, the
expression of the Rv2019D4K mutant inhibited colony formation
of BL21(DE3) to an extent similar to that of wild-type Rv2019. In
contrast, the Rv2019E41K and Rv2019D98K mutants did not inhibit
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FIGURE 2 | Phenotypes of five putative toxin-antitoxin systems and mutant Rv2019 proteins. (A) Inhibition of colony formation of E. coli BL21(DE3)
expressing Rv2019 toxin. BL21(DE3) harboring plasmid pBAD33, pBAD33-toxin, pET21c, or pET21c-antitoxin was collected during the exponential phase and
harvested by centrifugation. The cell pellet was resuspended to an optical density at 600 nm (OD600) = 0.2 in M9 minimal media and diluted 10−1, 10−2, 10−3, and
10−4 folds. Each diluted sample was spotted on M9 agar plates. (B) Growth curves of E. coli BL21(DE3) expressing toxin or antitoxin. BL21(DE3) harboring the
plasmids pBAD33, pBAD33-toxin, pET21c, or pET21c-antitoxin was diluted during the exponential phase, and the inducer was added at a time defined as 0 h.
Cultures were diluted at every 2 h, and OD600 was measured. (C) Colony formation of E. coli BL21(DE3) expressing wild-type and mutant Rv2019 proteins.
BL21(DE3) harboring pBAD33, pBAD33-Rv2019, pBAD33-Rv2019D4K , pBAD33-Rv2019E41K , or pBAD33-Rv2019D98K was spotted on M9 agar plates in a manner
similar to that described in (A).
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FIGURE 3 | Neutralization of the toxic effect of Rv2019 by the Rv2018 antitoxin. (A) Recovered colony formation of BL21(DE3) coexpressing Rv2019 and
Rv2018. BL21(DE3) harboring compatible plasmid pairs (pBAD33 and pET21c, pBAD33-Rv2019 and pET21c, pBAD33 and pET21c-Rv2018, or pBAD33-Rv2019
and pET21c-Rv2018) was diluted during the exponential phase. The cells were harvested by centrifugation, resuspended to OD600 = 0.2 in M9 minimal media, and
diluted 10−1, 10−2, 10−3, and 10−4 folds. Each of the diluted samples was spotted on M9 agar plates. (B) Growth curve of BL21(DE3) coexpressing Rv2019 and
Rv2018. BL21(DE3) harboring pBAD33-Rv2019 and pET21c-Rv2018 was diluted fivefold in fresh M9 minimal media during the exponential phase, and inducer was
added at 0 h. Cultures were continuously diluted fivefold in fresh M9 minimal media containing inducers every 2 h, and OD600 was measured.
colony formation of BL21(DE3). These results suggest that Glu41
and Asp98, but not Asp4, play a pivotal role in the toxicity of
Rv2019 and coordination of metal ion and that the toxicity is
solely due to the expression of Rv2019.
Neutralization of the Rv2019 Toxin by the
Rv2018 Antitoxin
In exponentially growing healthy cells, all toxins are
constitutively expressed and interact with their cognate
antitoxins, either protein or RNA molecules, except for the Type
IV TA system. This association prevents the function of a toxin
by neutralizing its toxicity. Therefore, to examine whether the
toxic effect of Rv2019 was neutralized by its cognate Rv2018
antitoxin, E. coli BL21(DE3) was cotransformed with compatible
plasmid pairs (pBAD33 and pET21c, pBAD33-Rv2019 and
pET21c, pBAD33 and pET21c-Rv2018, or pBAD33-Rv2019
and pET21c-Rv2018). In BL21(DE3) cotransformants, the
expression of the gene encoding the Rv2019 toxin or the Rv2018
antitoxin was independently induced by 0.2% L-arabinose
or 0.05 mM IPTG and coinduced when 0.2% L-arabinose
and 0.05 mM IPTG were added together. We found that the
expression of the Rv2019 toxin inhibited colony formation of
BL21(DE3) in the presence of arabinose (Figure 3A), which
is consistent with the previous result (Figure 2A). However,
coexpression of the Rv2019 toxin and the cognate Rv2018
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FIGURE 4 | Ribosomal RNA cleavage activity of Rv2019 in vivo. (A) Ribonuclease activity of Rv2019. BL21(DE3) harboring pBAD33 or pBAD33-Rv2019 was
cultivated, and toxin induction was performed, as shown in Figure 2B. Total nucleic acids were extracted using phenol, as described in the section “Materials and
Methods.” Ethidium bromide staining was used to visualize total nucleic acids. (B) Comparison of the relative abundance of 23S and 16S rRNA bands. The
intensities of 23S and 16S rRNA bands were quantified using ImageJ software. The ratio of 23S rRNA/(16S+23S rRNA) and 16S rRNA/(16S+23S rRNA) was
calculated and normalized to the band density of 16S+23S rRNA in the first lane (0 h). The bar graph shows a change of the values from 0 h to x h (0, 2, 4, and 6 h).
(C) Relative densities of 5S rRNA and small RNA bands. The intensities of 5S rRNA and small RNA bands were quantified using ImageJ software, and the values
were normalized to the standard in the first lane (0 h).
antitoxin recovered normal colony formation of BL21(DE3)
in the presence of both inducers. Similar results were obtained
using liquid cultures (Figure 3B). Furthermore, a reciprocal
exchange in expression vectors yielded the same results
(Supplementary Figure S2A). Thus, these findings demonstrate
that the expression of the Rv2019 toxin is toxic to E. coli and
its cognate antitoxin Rv2018 counteracts the toxic effect of the
Rv2019 toxin.
Ribonuclease Activity of the Rv2019
Toxin In vivo
In many bacteria, various VapC homologs exhibit ribonuclease
activity in vitro or in vivo (Ramage et al., 2009; Maezato
et al., 2011; Winther and Gerdes, 2011; McKenzie et al., 2012a;
Winther et al., 2013; Lopes et al., 2014). Therefore, we decided
to investigate the ribonuclease activity of the Rv2019 toxin
in vivo. First, we determined the amount of and pattern changes
of total nucleic acids extracted from cells after inducing the
expression of the Rv2019 toxin. The expression of the Rv2019
toxin was induced by adding L-arabinose to exponential phase
cells harboring pBAD33 or pBAD33-Rv2019, and OD600 was
measured at 2-h intervals. The same number of cells was
harvested at each time point, and total nucleic acids were
extracted using phenol. In the presence of L-arabinose, control
cells exhibited normal exponential growth, and the level of total
nucleic acids remained constant after induction (Figure 4A).
However, after the expression of the Rv2019 toxin, we found that
23S rRNA level gradually decreased, and that more interestingly,
the amount of small RNAs increased for 6 h. The intensities of
the 23S and 16S rRNA and small RNA bands were analyzed using
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FIGURE 5 | Ribosomal RNA cleavage activity of Rv2019 in vitro. Total RNAs were isolated from E. coli BL21(DE3) using the hot phenol method. In total, 15
pmole of GST-Rv2019 was incubated with 2 µg of total RNA in 50 mM Tris–HCl (pH 8.0). (A) Time-dependent ribonuclease activity of Rv2019. GST-Rv2019 was
incubated with the substrate for 0 to 90 min. Cleavage assay was independently performed three times. (B) Relative density of RNA bands. ImageJ software was
used for quantification and normalization. (C) Inhibition of ribonuclease activity of Rv2019 by EDTA. GST-Rv2019 was incubated for 15 min with increasing amounts
of metal ion (0.0015, 0.015, 0.15, 1.5, and 15 mM) before the addition of total RNA with or without 60 mM EDTA. The reaction mixture was incubated for 10 min.
ImageJ software. Figure 4B shows that after the induction of
the Rv2019 toxin, the levels of 23S and 16S rRNAs substantially
declined after 6 h, and the levels of small RNAs increased
(Figure 4C), indicating the accumulation of fragments of 23S
and 16S rRNAs. The amount of genomic DNA at the top
of the gel remained constant, indicating the RNA-specific
activity of Rv2019. These results suggest that the Rv2019 toxin
degrades rRNA and that its activity inhibits the growth of
BL21(DE3).
Ribonuclease Activity of Rv2019 Toxin In
vitro
To detect the ribonuclease activity of the Rv2019 toxin in vitro,
we cloned pGST-Rv2019, which produces a GST-Rv2019 chimera,
and tested its effects on the growth of BL21(DE3) (Supplementary
Figure S3B). The coexpression of GST-Rv2019 and Rv2018
recovered the normal growth of BL21(DE3) (Supplementary
Figure S3C). Next, we extracted total RNAs from exponentially
growing BL21(DE3) and purified GST and GST-fused Rv2019
(GST-Rv2019). Purified GST or GST-Rv2019 (15 pmoles each)
was incubated with 2 µg of total E. coli RNAs for 90 min at
37◦C in 50 mM Tris–HCl (pH 8.0). As shown in Figure 5A,
total E. coli RNAs were cleaved by purified GST-Rv2019, and the
activity increased with time. Moreover, RNA was not detectably
digested in the absence of GST-Rv2019 or by GST. Notably, the
intensity of 23S rRNA abruptly decreased after 10 min; however,
16S rRNA began to disappear after 30 min (Figure 5B, left)
with a concomitant increase in the intensities of smaller RNAs
(Figure 5B, right). Therefore, the purified Rv2019 toxin degrades
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FIGURE 6 | Quantitative real-time PCR analysis of mRNAs with or without induction of Rv2019. (A) Diagram of five genes of E. coli BL21(DE3) and
amplicons. The arrows indicate the primers used for qRT-PCR analysis, and the lines correspond to amplicons. (B) qRT-PCR analysis of ileS, dnaA, glyS, holA, and
rpoA mRNAs. For qRT-PCR, total RNA was extracted from BL21(DE3) harboring pBAD33 (black bars) or pBAD33-Rv2019 (gray bars) after induction for 8 h.
qRT-PCR was independently performed three times, as described in the section “Materials and Methods,” and a representative result is shown. Data are shown in
fold change compared to control (pBAD33).
rRNA in vitro as well as in vivo. Interestingly, the in vitro results
showed that the Rv2019 toxin preferentially cleaved 23S rRNA.
Unfortunately, although the Rv2018 antitoxin antagonized the
activity of the GST-Rv2019 toxin in vivo (Supplementary
Figure S3C), the addition of a purified N-terminal His6-tagged
Rv2018 (antitoxin) to the reaction mixture did not inhibit the
ribonuclease activity of the toxin (Supplementary Figure S4A).
It is therefore very likely that improper association conditions
inhibit the binding of the antitoxin to the toxin, as we confirmed
the counteracting activity of His-Rv2018 to GST-Rv2019 in vivo
(Supplementary Figure S4B).
The activities of VapC toxins of various bacteria depend on
Mg2+, Mn2+, or both (Ahidjo et al., 2011; McKenzie et al.,
2012a,b; Lopes et al., 2014). Therefore, we tested the effects of
Mg2+ and Mn2+ on the ribonuclease activity of the Rv2019
toxin. In this assay, the reaction was incubated for 10 min
instead of 90 min to detect the enhanced activity in the presence
of 0.0015, 0.015, 0.15, 1.5, or 15 mM metal ions. Increasing
the concentrations of metal ions did not enhance the catalytic
activity, and the 23S and 16S RNAs were not digested in
the presence of EDTA. When we performed the reactions in
the presence of Cu2+, Ca2+, or Co2+, the results were the
same (Supplementary Figure S4C). This is likely due to the
incorporation of metal ions into the proteins during cultivation
and purification, suggesting that metal ions are required for the
ribonuclease activity of Rv2019 (Figure 5C).
Effects of Rv2019 on mRNAs
Next, we determined whether Rv2019 digested mRNAs. For this
purpose, we selected the E. coli BL21(DE3) genes (ileS and dnaA,
∼3 kb; glyS, ∼2 kb; and holA and rpoA, ∼1 kb) and used qRT-
PCR to amplify specific regions of each. The expression of the
Rv2019 toxin was induced by adding L-arabinose to exponential
phase cells harboring pBAD33 or pBAD33-Rv2019, and total
RNAs were extracted after induction for 8 h. To amplify specific
regions of five mRNAs, we designed primer sets that generate
an approximately ∼400-bp amplicon (Figure 6A). The cDNA
synthesized from total RNA was subjected to qRT-PCR, and the
differences in relative expression for each gene are shown in
Figure 6B. The relative mRNA amounts of ileS1, ileS2, dnaA1,
dnaA2, glyS1, glyS2, and holA were significantly lower (∼9-fold)
when the Rv2019 toxin was expressed. However, the transcript
amount of rpoA was marginally lower in the presence of the
Rv2019 toxin, suggesting that Rv2019 may not cleave the rpoA
transcript. Therefore, our results show that ileS, dnaA, glyS, and
holA mRNAs serve as substrates for the Rv2019 toxin and that
the seven specific regions of these mRNAs contain the sequence
cleaved by Rv2019. Based on these results, mRNA was likely
digested by the ribonuclease activity of the Rv2019 toxin.
Assessment of the Toxic Effects of 5 Mtb
Toxins on M. smegmatis
So far, we determined the toxicities of five putative Mtb toxins
to E. coli and found that only the Rv2019 toxin caused toxicity,
presumably through its ribonuclease activity. Therefore, we
assessed the toxic effects of five candidate Mtb TA systems
on a non-pathogenic species M. smegmatis, which is closely
related to Mtb. For this purpose, we constructed expression
vectors in pMV306AC, which harbors an acetamide-inducible
promoter and integrates into the attB site of M. smegmatis
genomic DNA. The resulting plasmids pMV306AC-Rv2019,
pMV306AC-Rv2018-2019, pMV306AC-Rv3697c, pMV306AC-
Rv3180c, pMV306AC-Rv3180c-3181c, pMV306AC-Rv0299,
and pMV306AC-Rv3749c were individually transformed and
integrated into the genome of M. smegmatis, as described in
the section “Materials and Methods.” The initial transformation
results showed that the transformation efficiency of pMV306AC-
Rv2019 was significantly lower than those of the other
vectors (Figure 7A, plate 2). However, the transformation
of pMV306AC-Rv2018-2019 resulted in the similar colony
number with that obtained from control vector (Figure 7A,
plate 6). This suggests that transient expression of Rv2019 is toxic
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FIGURE 7 | Toxic effect of the five toxins on the growth of
M. smegmatis. (A) Transformation of pMV306AC-toxin plasmid into
M. smegmatis mc2 155. One microgram of DNA was electrophorated and
cells were plated on Middlebrook 7H10 solid media. The plates were
incubated for 3 days at 37◦C. (B) Effect of toxin on the induction on colony
formation of M. smegmatis mc2 155. Each transformant from (A) was grown
for 3 days at 37◦C. The culture was diluted 100-fold into Middlebrook 7H9
liquid media and streaked on Middlebrook 7H10 solid media in the absence
and presence of 0.2% acetamide. The numbers in the circle correspond to
those in (A).
to M. smegmatis and this toxicity was reverted by the expression
of antitoxin, Rv2018. Interestingly, when we streaked colonies
formed on the initial plates, only the Rv3180c toxin inhibited
colony formation of M. smegmatis in the presence of 0.2%
acetamide (Figure 7B, sector 3). This toxicity was neutralized by
the antitoxin Rv3181c (Figure 7B, sector 7). Further, we found
that only the Rv3180c toxin inhibited the growth of M. smegmatis
after the addition of acetamide to cells cultured in liquid
Middlebrook 7H9 containing 0.2% glycerol and 0.02% Tween 80
(data not shown). Peculiarly, however, the cells transformed with
pMV306AC-Rv2019 did not exhibit an inhibitory phenotype
upon induction (Figure 7B, sector 2). These findings raise
the possibility that mutation, rearrangement, or both of the
promoter or the locus harboring Rv2019 prevents the expression
of Rv2019, and sequencing analysis revealed that transformants
of pMV306AC-Rv2019 harbor several spontaneous mutations in
the open reading frame of Rv2019 (data not shown). Therefore,
our results demonstrate that the expression of Rv2019 and
Rv3180c inhibited the growth of M. smegmatis, and their cognate
antitoxins counteracted the toxicities of toxins.
DISCUSSION
Mycobacterium tuberculosis possesses 50 putative VapBC TA
systems. The structures of the complexes formed by VapBC3,
VapBC5, VapBC15, and VapBC30 have been determined (Miallau
et al., 2009; Min et al., 2012; Das et al., 2014; Lee et al.,
2015). The active sites of VapC toxins consist of three or four
highly conserved acidic residues that bind to Mg2+, Mn2+,
or both, which is a characteristic of the PIN domain. These
divalent metal ions coordinate with acidic residues and form a
concave active site, thereby helping to stabilize the interaction
with negatively charged RNA that is required for RNase activity
(Ahidjo et al., 2011; McKenzie et al., 2012a,b; Lopes et al.,
2014).
When expressed in E. coli, the VapC homolog Rv2019
toxin, which triggered a growth defect, was neutralized by
its cognate antitoxin Rv2018. The Rv2019 toxin appeared to
possess ribonuclease activity using free rRNA as a substrate
in vivo and in vitro. The Rv2019 toxin cleaved rRNA
less effectively in vivo than in vitro, likely due to the
association of the rRNA with ribosomal proteins in vivo.
Interestingly, the digestion rate of 23S rRNA was much
faster than that of 16S rRNA, indicating more preferred
target sites on 23S rRNA. Presumably, this RNase activity is
either sequence- or conformation-specific, nevertheless, it is
likely that cleavage site specificity of Rv2019 is quite low,
resulting in small RNA accumulation. However, this activity was
inhibited in the presence of EDTA. Metal ion dependence was
further supported by analysis of the mutants Rv2019E41K and
Rv2019D98K (Figure 2C). Interestingly, in M. smegmatis, initial
transformation of pMV306AC-Rv2019 negatively affected the
colony formation, yielding the substantially low transformation
efficiency of pMV306AC-Rv2019, meanwhile, this effect was
masked by the expression of Rv2018 (Figure 7A). This
demonstrates that Rv2019 is paired with Rv2018. Therefore,
our findings demonstrate that Rv2019 is a bona fide VapC
toxin.
Among five putative toxins, only RV2019 inhibited colony
formation after its expression was induced in E. coli, which
prompted us to determine the induction level of each
recombinant protein. Unfortunately, we were unable to detect
significant protein induction using SDS-PAGE (data not shown),
nevertheless, the low expression level of Rv2019 was sufficient to
cause toxicity.
We next attempted to express GST-fused toxin proteins
to determine whether a higher level of expression induced
a different phenotype of cell growth. The fusion of each
toxin with GST-tag apparently increased the level of induction
(Supplementary Figure S3A), and we detected the same toxic
phenotype of cells that expressed GST-Rv2019. Notably, serial
dilutions of cells that expressed GST-Rv0299 formed less dense
colonies, suggesting that GST-Rv0299 was marginally toxic
(Supplementary Figure S3B). In E. coli MazF, there are seven
amino acid residues, Asp16, Asp18, Glu24, Arg29, Gly66, Asp76,
and Arg86 that are involved in the substrate binding, and out of
these seven residues, Glu24 and Arg29 are pivotal for catalytic
activity of MazF. However, Rv2099 conserved only Asp16 and
Glu24 (residue numbers as in E. coli MazF), which might explain
the marginal toxicity (Li et al., 2006). Therefore, further studies
are required to determine the mechanism of toxicity of Rv2099 as
a putative MazF homolog.
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Interestingly, compared with the results shown in Figure 2;
Supplementary Figure S3B, the expression of C-terminal His6-
Rv2019 toxin exhibited a reduced toxic effect (Supplementary
Figure S2B). This is probably why the active site is sterically
hindered by the His-tag at the C-terminal region which points
the incurvate catalytic site (Miallau et al., 2009; Min et al., 2012;
Das et al., 2014; Lee et al., 2015).
Type II TA families were originally classified according to
their amino acid sequences and three-dimensional structural
similarities of their respective toxins (Pandey and Gerdes,
2005). Further, each toxin was paired with its cognate antitoxin
depending on their specific interactions, e.g., VapBC and MazEF
(Zhang J. et al., 2003; Lopes et al., 2014). Among VapC
homologs containing the PIN domain, the majority of toxins
interact with antitoxins containing a ribbon–helix–helix (RHH)
domain. However, several antitoxins with PHD, AbrB, COG2442,
COG2886, MerR, or Xre domains interact with the VapC toxin
(Makarova et al., 2009).
In the Rv3180c-Rv3181c TA system, the Rv3180c toxin,
which contains a PIN domain, has been predicted to possess
ribonuclease activity, and the Rv3181c antitoxin possesses a
PHD domain that is recently expected to associate with PIN
domain toxins (Makarova et al., 2009). Therefore, the antitoxin
containing a PHD domain was considered to interact with a
toxin containing the PIN domain. Moreover, it has recently
been revealed that a toxin and non-cognate antitoxin interact,
and therefore, TA families are independently divided into 12
super-families of Type II toxins and 20 super-families of Type II
antitoxins, respectively (Leplae et al., 2011).
There are potentially nine TA systems (one MazF homolog,
one VapC homolog, and seven putative TA systems) in
M. smegmatis and 33 TA modules in E. coli (Shao et al.,
2011; Yamaguchi et al., 2011). It should be noted that neither
native nor highly expressed GST-fused Rv3180c was toxic
to E. coli (Supplementary Figure S3), suggesting a lack of
relationship between expression level and toxicity. Unlike in
E. coli, M. smegmatis cells could not form colonies upon
induction of Rv3180c.
Therefore, it is possible that Rv3180c may be neutralized
by non-cognate antitoxins present in E. coli or that structural
conformation of Rv3180c is different in E. coli and M. smegmatis.
In the present study, we cloned 5 putative Mtb TA
modules and expressed them in E. coli and M. smegmatis.
Our results revealed that the novel toxin Rv2019 is an RNase
that degrades rRNAs and mRNAs and that the Rv2019 and
Rv3180c toxins and their cognate Rv2018 and Rv3181c antitoxins
functionally associate, respectively. Further studies are required
to characterize the other four TA systems. Considering the vast
numbers of TA systems of the M. tuberculosis complex, including
Mtb, such studies promise to contribute to a better understanding
of the importance of Mtb TA systems for controlling latency,
persistence, biofilm formation, and stress response.
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